Andrew Haydon

Adj Assoc Prof

20022025

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Abstract
2018

Patients’ preferences for 3 months versus 6 months of adjuvant chemotherapy (ACT) for colon cancer in the SCOT trial: what survival benefits make longer chemotherapy worthwhile?

Segelov, E., Blinman, P., Martin, A., Goldstein, D., Cronk, M., Boadle, D., Tebbutt, N., Paul, J. & Haydon, A., 2018.

Research output: Contribution to conferenceAbstract

2015

The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation- analysis of outcomes in patients with refractory metastatic colorectal cancer harbouring the KRAS G13D mutation.

Segelov, E., Thavaneswaran, S., Waring, P., Desai, J., Mann, K., Elez, M. E., Chantrill, L. A., Pavlakis, N., Nott, L., Underhill, C., Khasraw, M., Wasan, H., Ciardiello, F., Jefford, M. J., Joubert, W., Haydon, A. M. M., Karapetis, C., Price, T. J., Wilson, K. & Shapiro, J., 2015, p. S726. 1 p.

Research output: Contribution to conferenceAbstract